Current issue
About the Journal
Scientific Council
Editorial Board
Regulatory and archival policy
Code of publishing ethics
Publisher
Information about the processing of personal data in relation to cookies and newsletter subscription
Archive
For Authors
For Reviewers
Contact
Reviewers
Annals reviewers in 2022
Annals reviewers in 2021
Annals reviewers in 2020
Annals reviewers in 2019
Annals reviewers in 2018
Annals reviewers in 2017
Annals reviewers in 2016
Annals reviewers in 2015
Annals reviewers in 2014
Annals reviewers in 2013
Annals reviewers in 2012
Links
Sklep Wydawnictwa SUM
Biblioteka Główna SUM
Śląski Uniwersytet Medyczny w Katowicach
Privacy policy
Accessibility statement
Neuroendocrine carcinoma of the mammary gland. A case report of synchronous occurrence of two different carcinomas in one breast
| 1 | Department of Oncological Surgery, School of Medicine with the Division of Dentistry in Zabrze,
Medical University of Silesia, Katowice, Poland |
| 2 | Department of Oncology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland |
CORRESPONDING AUTHOR
Andrzej Jarosław Lorek
Department of Oncological Surgery, School of Medicine with the Division of Dentistry in Zabrze, University Clinical Center to them. prof. K. Gibińskiego Medical University of Silesia in Katowice, ul. Ceglana 35, 40-514 Katowice, Poland
Department of Oncological Surgery, School of Medicine with the Division of Dentistry in Zabrze, University Clinical Center to them. prof. K. Gibińskiego Medical University of Silesia in Katowice, ul. Ceglana 35, 40-514 Katowice, Poland
Ann. Acad. Med. Siles. 2018;72:252–256
KEYWORDS
TOPICS
ABSTRACT
The paper presents a case of primary neuroendocrine breast carcinoma that coexisted with a typical infiltrating carcinoma (BC) within the same mammary gland. It was diagnosed post-operatively on histopathological examination and confirmed by immunohistochemical analysis.
REFERENCES (16)
1.
Ogawa H., Nishio A., Satake H., Naganawa S., Imai T., Sawaki M., Yamamoto E., Miyata T. Neuroendocrine tumor in the breast. Radiat. Med. 2008; 26(1): 28–32, doi: 10.1007/s11604-007-0182-y.
2.
Tavassoli F.A., Devilee P. Tumours of the breast. In: Pathology and genetics of tumours of the breast and female genital organs. Tavassoli F.A., Devilee P. (Ed.) World Health Organization Classification of Tumours Series. Lyon: IARC Press; 2003, pp. 32–34.
3.
Günhan-Bilgen I., Zekioglu O., Ustün E.E., Memis A., Erhan Y. Neuroendocrine differentiated breast carcinoma: imaging features correlated with clinical and histopathological findings. Eur. Radiol. 2003; 13(4): 788–793.
4.
Akhtar K., Zaheer S., Ahmad S.S., Hassan M.J. Primary neuroendocrine carcinoma of the breast. Indian J. Pathol. Microbiol. 2009; 52(1): 71–73.
5.
Adegbola T., Connolly C.E., Mortimer G. Small cell neuroendocrine carcinoma of the breast: a report of three cases and review of the literature. J. Clin. Pathol. 2005; 58(7): 775–778.
6.
Sapino A., Righi L., Cassoni P., Papotti M., Gugliotta P., Bussolati G. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women. Mod. Pathol. 2001; 14(8): 768–776.
7.
Yamaguchi R., Furusawa H., Nakahara H., Inomata M., Namba K., Tanaka M., Ohkuma K., Tayama K., Fujii T., Yano H., Kage M., Kojiro M. Clinicopathological study of invasive ductal carcinoma with large central acellular zone: special reference to magnetic resonance imaging findings. Pathol. Int. 2008; 58(1): 26–30.
8.
Miremadi A., Pinder S.E., Lee A.H., Bell J.A., Paish E.C., Wencyk P., Elston C.W., Nicholson R.I., Blamey R.W., Robertson J.F., Ellis I.O. Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology 2002; 40(3): 215–222.
9.
Menéndez P., García E., Rabadán L., Pardo R., Padilla D., Villarejo P. Primary neuroendocrine breast carcinoma. Clin. Breast Cancer 2012; 12(4): 300–303, doi: 10.1016/j.clbc.2012.03.001.
10.
Singh S., Aggarwal G., Kataria S.P., Kalra R., Duhan A., Sen R. Primary neuroendocrine carcinoma of breast. J. Cytol. 2011; 28(2): 91–92, doi: 10.4103/0970-9371.80755.
11.
Angarita F.A., Rodríguez J.L., Meek E., Sánchez J.O., Tawil M., Torregrosa L. Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature. World J. Surg. Oncol. 2013; 11: 128, doi: 10.1186/1477-7819-11-128.
12.
Kim J.W., Woo O.H., Cho K.R., Seo B.K., Yong H.S., Kim A., Kang E.Y. Primary large cell neuroendocrine carcinoma of the breast: radiologic and pathologic findings. J. Korean Med. Sci. 2008; 23(6): 1118–1120, doi: 10.3346/jkms.2008.23.6.1118.
13.
Chmielik E., Olszewski W.P. Rak naciekający piersi. W: Zalecenia do diagnostyki histopatologicznej nowotworów. Red.: A. Nasierowska-Guttmejer, B. Górnicka. Wyd. Centrum Onkologii, Oddział Gliwice. Polskie Towarzystwo Patologów. Warszawa 2013, s. 39.
14.
Latif N., Rosa M., Samian L., Rana F. An unusual case of primary small cell neuroendocrine carcinoma of the breast. Breast J. 2010; 16(6): 647–651, doi: 10.1111/j.1524-4741.2010.00974.x.
15.
Adams R.W., Dyson P., Barthelmes L. Neuroendocrine breast tumours: breast cancer or neuroendocrine cancer presenting in the breast? Breast 2014; 23(2): 120–127, doi: 10.1016/j.breast.2013.11.005.
16.
Alkaied H., Harris K., Azab B., Dai Q. Primary neuroendocrine breast cancer, how much do we know so far? Med. Oncol. 2012; 29(4): 2613–2618, doi: 10.1007/s12032-012-0222-z.
Share
RELATED ARTICLE
The Medical University of Silesia in Katowice, as the Operator of the annales.sum.edu.pl website, processes personal data collected when visiting the website. The function of obtaining information about Users and their behavior is carried out by voluntarily entered information in forms, saving cookies in end devices, as well as by collecting web server logs, which are in the possession of the website Operator. Data, including cookies, are used to provide services in accordance with the Privacy policy.
You can consent to the processing of data for these purposes, refuse consent or access more detailed information.
You can consent to the processing of data for these purposes, refuse consent or access more detailed information.